Person Centred Software is piloting a first-of-its-kind approach to integrating health and social care services, which is making the London Care Record more widely accessible.The company has teamed up with OneLondon and the NHS…
Continue Reading
Jeremy Bloom, CEO, NorthSight RecoveryThe United States only represents five percent of the world’s population; however, Americans consume 80 percent of the world’s opioids.1 The U.S. is the world’s leader in the use of…
Continue Reading
By Sarai Rodriguez
March 15, 2023 – As states increasingly prioritize improved healthcare quality, the promotion of health information exchange (HIE) has become a key focus. However, the key to increasing HIE use may…
By Hannah Nelson
March 08, 2023 – DirectTrust has been selected as part of the Amazon Web Services (AWS) Health Equity Initiative to enhance the DirectTrust Directory for health data exchange.
DirectTrust is a non-profit…
By Hannah Nelson
March 07, 2023 – CRISP, Maryland’s state-designated health information exchange (HIE), has expanded its Medicaid Redetermination Notification project to all interested providers and Managed Care Organizations (MCOs).
The program aims to…
What You Should Know:– CRISP, the nonprofit state-designated health information exchange (HIE) of Maryland, announced plans to expand its Medicaid Redetermination Notification project across the state to support care teams as they navigate redetermination for…
Continue Reading
Tillmann Schwabe, General Manager of Everphone U.S.The Great Resignation changed how companies approach attracting and retaining talent. These days, it’s not enough to offer a competitive salary and traditional benefits like health insurance…
Continue Reading
A Chiesi Farmaceutici drug for a rare enzyme deficiency is now approved by the FDA, making it the first U.S. treatment for a disorder that leads to a range of cognitive and muscle problems.
The regulatory decision announced late Thursday covers the treatment of children and adults who have alpha-mannosidosis (AM), a disease caused by a genetic mutation that leads to defective or inactive forms of an enzyme called alpha-D-mannosidase. Chiesi’s drug, velmanase alfa, is an engineered version of that enzyme. The privately held Italian company will market its new FDA-approved drug as Lamzede, the same name for the product in Europe,…
ONC launched the Strengthening the Technical Advancement and Readiness of Public Health Agencies via Health Information Exchange (STAR HIE) Program in 2020 using funding from the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). The program was expanded in 2021 to increase support for efforts to improve vaccination data sharing between jurisdictional Immunization Information Systems (IIS) and HIEs. The West Virginia Health Information Network (WVHIN) was among the 22 recipients that received a combined $20 million in funds from ONC via the CARES Act.We sat down with WVHIN’s Executive Director, Sonia Chambers, to learn how the STAR HIE Program helped…
Continue Reading
